Cleveland BioLabs (CBLI) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free CBLI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEagles' Tyrie Cleveland, Moro Ojomo carted off field after suffering neck injuriesusatoday.com - September 2 at 3:42 PMCleveland Construction Newsbizjournals.com - July 28 at 9:58 PMBest Hospitals in Cleveland, OHhealth.usnews.com - June 28 at 7:35 PMCleveland EMS worker who went missing for 6 days remains hospitalized after found safeabcnews.go.com - May 22 at 6:29 PMCleveland Clinic Rehabilitation Hospitalhealth.usnews.com - May 17 at 2:24 PMGetting Around Clevelandtravel.usnews.com - April 19 at 12:40 AMCleveland BioLabs Stock Gaps Down On Today's Open (CBLI)thestreet.com - March 31 at 9:53 PMCleveland Manufacturing Newsbizjournals.com - March 23 at 9:12 AMCleveland Commercial Real Estate Newsbizjournals.com - March 16 at 9:59 AMCleveland, TNforbes.com - March 12 at 5:24 PMCleveland Newsbizjournals.com - September 9 at 10:35 PM5 Stocks Under $5 Making Big Movesthestreet.com - August 31 at 10:06 PMStatera Biopharma Provides Third Quarter 2021 Financial and Corporate Updatefinance.yahoo.com - November 15 at 6:35 PMCleveland BioLabs Gets Orphan Status for Entolimod in EUfinance.yahoo.com - October 26 at 12:57 AMStatera Biopharma Increuters.com - September 24 at 12:29 PMWhat is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?finance.yahoo.com - September 8 at 2:42 PMStatera BioPharma: The Ticker Formerly Known as CBLIfinance.yahoo.com - September 7 at 3:45 PMCytocom to rename as Statera BioPharmaseekingalpha.com - September 2 at 10:15 PMCytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc."finance.yahoo.com - August 31 at 5:06 PMCytocom, Inc. (CBLI) CEO Michael Handley on Q2 2021 Results - Earnings Call Transcriptseekingalpha.com - August 18 at 3:56 AMCytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcastfinance.yahoo.com - August 16 at 3:33 PMCytocom, Inc. Reports Second Quarter 2021 Financial Resultsfinance.yahoo.com - August 16 at 9:28 AMCytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreementfinance.yahoo.com - August 12 at 7:00 PMCytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conferencefinance.yahoo.com - August 11 at 9:39 AMCytocom, Inc. to Report Second Quarter 2021 Financial Resultsfinance.yahoo.com - August 10 at 8:01 AMCytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19finance.yahoo.com - August 9 at 9:39 AMCytocom Inc. Provides Update on Completed Merger with Cleveland BioLabsfinance.yahoo.com - August 5 at 8:01 AMCytocom Inc. Announces Completed Merger with Cleveland BioLabsprnewswire.com - July 28 at 1:32 PM Get Cleveland BioLabs News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> CBLI Media Mentions By Week CBLI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CBLI News Sentiment▼0.000.32▲Average Medical News Sentiment CBLI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CBLI Articles This Week▼00▲CBLI Articles Average Week Get Cleveland BioLabs News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Statera Biopharma News Kaleido Biosciences News Bruush Oral Care News Humanigen News Context Therapeutics News Grifols News LAVA Therapeutics News Mainz Biomed News NLS Pharmaceutics News Pharvaris News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CBLI) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cleveland BioLabs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
